S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 361 to 420 of 565

Issue Date	Title / Author(s) / Citation	File
2017-10	Korean Cancer Patients' Awareness of Clinical Trials, Perceptions on the Benefit and Willingness to Participate Lim, Yoojoo; Lim, Jee Min; Jeong, Won Jae; Lee, Kyung-Hun; Keam, Bhumsuk; Kim, Tae-Yong; Kim, Tae Min; Han, Sae-Won; Oh, Do Youn; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.49 No.4, pp.1033-1043	view file DOI
2017-10	Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy Cho, Kyoung-Min; Park, Hyunkyung; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Oncotarget, Vol.8 No.45, pp.79441-79452	DOI
2017-10	Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial Kim, Sung-Bae; Dent, Rebecca; Im, Seock-Ah; Espie, Marc; Blau, Sibel; Tan, Antoinette R.; Isakoff, Steven J.; Oliveira, Mafalda; Saura, Cristina; Wongchenko, Matthew J.; Kapp, Amy V.; Chan, Wai Y.; Singel, Stina M.; Maslyar, Daniel J.; Baselga, Jose The Lancet Oncology, Vol.18 No.10, pp.1360-1372	DOI
2017-11	Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer Park, Yeon Hee; Im, Seock-Ah; Kim, Sung-Bae; Sohn, Joo Hyuk; Lee, Keun Seok; Chae, Yee Soo; Lee, Ki Hyeong; Kim, Jee Hyun; Im, Young-Hyuck; Kim, Ji-Yeon; Kim, Tae-Yong; Lee, Kyung-Hun; Ahn, Jin-Hee; Kim, Gun Min; Park, In Hae; Lee, Soo Jung; Han, Hye Sook; Kim, Se Hyun; Jung, Kyung Hae; Korean Cancer Study Group (KCSG) European Journal of Cancer, Vol.86, pp.385-393	DOI
2017-11	Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial (vol 165, pg 329, 2017) Cortes, Javier; Rugo, Hope S.; Awada, Ahmad; Twelves, Chris; Perez, Edith A.; Im, Seock-Ah; Gomez-Pardo, Patricia; Schwartzberg, Lee S.; Dieras, Veronique; Yardley, Denise A.; Potter, David A.; Mailliez, Audrey; Moreno-Aspitia, Alvaro; Ahn, Jin-Seok; Zhao, Carol; Hoch, Ute; Tagliaferri, Mary; Hannah, Alison L.; O'Shaughnessy, Joyce Breast Cancer Research and Treatment, Vol.166 No.1, pp.327-328	DOI
2017-12	Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial ExteNET Study Group; Im, Seock Ah The Lancet Oncology, Vol.18 No.12, pp.1688-1700	DOI
2017-12	Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline Sohn, Byeong Seok; Kim, Sung-Bae; Ahn, Jin-Hee; Jung, Kyung Hae; Kim, Jeongeun; Lee, Keun Seok; Ro, Jungsil; Im, Seock Ah; Im, Young-Hyuck; Song, Hong Suk; Park, Hee Sook; Chung, Hyun-Cheol Asia-Pacific Journal of Clinical Oncology, Vol.13 No.6, pp.365-371	DOI
2017-12	Cyclophosphamide, Methotrexate, and 5-Fluorouracil as Palliative Treatment for Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Retrospective Analysis Park, Jin Hyun; Im, Seock-Ah; Byun, Ja Min; Kim, Ki Hwan; Kim, Jin-Soo; Choi, In Sil; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do Youn; Kim, Tae-You Journal of Breast Cancer, Vol.20 No.4, pp.347-355	DOI
2017-12	Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial Bang, Yung-Jue; Xu, Rui-Hua; Chin, Keisho; Lee, Keun-Wook; Park, Se Hoon; Rha, Sun Young; Shen, Lin; Qin, Shukui; Xu, Nong; Im, Seock-Ah; Locker, Gershon; Rowe, Phil; Shi, Xiaojin; Hodgson, Darren; Liu, Yu-Zhen; Boku, Narikazu The Lancet Oncology, Vol.18 No.12, pp.1637-1651	DOI
2017-12	Treatment Patterns and Outcomes in Elderly Patients with Metastatic Breast Cancer: A Multicenter Retrospective Study Park, Jin Hyun; Choi, In Sil; Kim, Ki Hwan; Kim, Jin-Soo; Lee, Kyung-Hun; Kim, Tae-Yong; Im, Seock Ah; Kim, Se Hyun; Kim, Yu Jung; Kim, Jee Hyun Journal of Breast Cancer, Vol.20 No.4, pp.368-377	DOI
2017-12	The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies Cortes, Javier; Im, Seock-Ah; Holgado, Esther; Perez-Garcia, Jose M.; Schmid, Peter; Chavez-MacGregor, Mariana Cancer Treatment Reviews, Vol.61, pp.53-60	DOI
2018-03	Phase III, Randomized study of dual human epidermal growth factor receptor 2 (HER2) blockade with lapatinib plus trastuzumab in combination with an aromatase inhibitor in postmenopausal women with HER2-positive, hormone receptor-positive metastatic breast cancer: ALTERNATIVE Johnston, Stephen R. D.; Hegg, Roberto; Im, Seock-Ah; Park, In Hae; Burdaeva, Olga; Kurteva, Galina; Press, Michael F.; Tjulandin, Sergei; Iwata, Hiroji; Simon, Sergio D.; Kenny, Sarah; Sarp, Severine; Izquierdo, Miguel A.; Williams, Lisa S.; Gradishar, William J. Journal of Clinical Oncology, Vol.36 No.8, pp.741-748	DOI
2018-03	A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma Lee, Dae-Won; Lee, Kyung-Hun; Kim, Hee-Jun; Kim, Tae-Yong; Kim, Jin-Soo; Han, Sae-Won; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Kim, Tae-You BMC Cancer, Vol.18 No.1, p. 252	DOI
2018-03	Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases Turner, N. C.; Finn, R. S.; Martin, M.; Im, S. -A; DeMichele, A.; Ettl, J.; Dieras, V.; Moulder, S.; Lipatov, O.; Colleoni, M.; Cristofanilli, M.; Lu, D. R.; Mori, A.; Giorgetti, C.; Iyer, S.; Bartlett, C. Huang; Gelmon, K. A. Annals of Oncology, Vol.29 No.3, pp.669-680	DOI
2018-03	Integrated 18F-FDG PET/MRI in breast cancer: Early prediction of response to neoadjuvant chemotherapy Cho, Nariya; Im, Seock-Ah; Cheon, Gi Jeong; Park, In-Ae; Lee, Kyung-Hun; Kim, Tae-Yong; Kim, Young Seon; Kwon, Bo Ra; Lee, Jung Min; Suh, Hoon Young; Suh, Koung Jin European Journal of Nuclear Medicine and Molecular Imaging, Vol.45 No.3, pp.328-339	DOI
2018-04	A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results Pivot, X.; Bondarenko, I.; Nowecki, Z.; Dvorkin, M.; Trishkina, E.; Ahn, J. H.; Im, S. A.; Sarosiek, T.; Chatterjee, S.; Wojtukiewicz, M. Z.; Shparyk, Y.; Moiseyenko, V.; Bello, M., III; Semiglazov, V.; Lee, Y.; Lim, J. European Journal of Cancer, Vol.93, pp.19-27	DOI
2018-04	Phase III, randomized, double-blind study comparing the efficacy, safety, and immunogenicity of SB3 (trastuzumab biosimilar) and reference trastuzumab in patients treated with neoadjuvant therapy for human epidermal growth factor receptor 2-positive early breast cancer Pivot, Xavier; Bondarenko, Igor; Nowecki, Zbigniew; Dvorkin, Mikhail; Trishkina, Ekaterina; Ahn, Jin-Hee; Vinnyk, Yuriy; Im, Seock-Ah; Sarosiek, Tomasz; Chatterjee, Sanjoy; Wojtukiewicz, Marek Z.; Moiseyenko, Vladimir; Shparyk, Yaroslav; Bello, Maximino, III; Semiglazov, Vladimir; Song, Sujeong; Lim, Jaeyun Journal of Clinical Oncology, Vol.36 No.10, pp.968-974	DOI
2018-04	Profiling of protein-protein interactions via single-molecule techniques predicts the dependence of cancers on growth-factor receptors Lee, Hong-Won; Choi, Byoungsan; Kang, Han Na; Kim, Hyunwoo; Min, Ahrum; Cha, Minkwon; Ryu, Ji Young; Park, Sangwoo; Sohn, Jinyoung; Shin, Kihyuk; Yun, Mi Ran; Han, Joo Yeun; Shon, Min Ju; Jeong, Cherlhyun; Chung, Junho; Lee, Seung-Hyo; Im, Seock-Ah; Cho, Byoung Chul; Yoon, Tae-Young Nature Biomedical Engineering, Vol.2 No.4, pp.239-253	DOI
2018-05	Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells Min, Ahrum; Kim, Jung Eun; Kim, Yu-Jin; Lim, Jee Min; Kim, Seongyeong; Kim, Jin Won; Lee, Kyung-Hun; Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue; Im, Seock-Ah Cancer Letters, Vol.430, pp.123-132	DOI
2018-05	Pre-treatment anxiety is associated with persistent chemotherapy-induced peripheral neuropathy in women treated with neoadjuvant chemotherapy for breast cancer Lee, Kwang-Min; Jung, Dooyoung; Hwang, Heesung; Son, Kyung-Lak; Kim, Tae-Yong; Im, Seock-Ah; Lee, Kyung-Hun; Hahm, Bong-Jin Journal of Psychosomatic Research, Vol.108, pp.14-19	DOI
2018-05	Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine Pivot, Xavier; Im, Seock Ah; Guo, Matthew; Marme, Frederik Breast Cancer, Vol.25 No.3, pp.370-374	DOI
2018-06	Safety and antitumor activity of pembrolizumab in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer Rugo, Hope S.; Delord, Jean-Pierre; Im, Seock-Ah; Ott, Patrick A.; Piha-Paul, Sarina A.; Bedard, Philippe L.; Sachdev, Jasgit; Le Tourneau, Christophe; van Brummelen, Emilie M. J.; Varga, Andrea; Salgado, Roberto; Loi, Sherene; Saraf, Sanatan; Pietrangelo, Dina; Karantza, Vassiliki; Tan, Antoinette R. Clinical Cancer Research, Vol.24 No.12, pp.2804-2811	DOI
2018-07	Change in topoisomerase 1–positive circulating tumor cells affects overall survival in patients with advanced breast cancer after treatment with etirinotecan pegol Rugo, Hope S.; Cortes, Javier; Awada, Ahmad; O'Shaughnessy, Joyce; Twelves, Chris; Im, Seock-Ah; Hannah, Alison; Lu, Lin; Sy, Sherwin; Caygill, Katie; Zajchowski, Deborah A.; Davis, Darren W.; Tagliaferri, Mary; Hoch, Ute; Perez, Edith A. Clinical Cancer Research, Vol.24 No.14, pp.3348-3357	DOI
2018-07	Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial Tripathy, Debu; Im, Seock-Ah; Colleoni, Marco; Franke, Fabio; Bardia, Aditya; Harbeck, Nadia; Hurvitz, Sara A.; Chow, Louis; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Vazquez, Rafael Villanueva; Jung, Kyung Hae; Babu, K. Govind; Wheatley-Price, Paul; De laurentiis, Michelino; Im, Young-Hyuck; Kuemmel, Sherko; El-Saghir, Nagi; Liu, Mei-Ching; Carlson, Gary; Hughes, Gareth; Diaz-Padilla, Ivan; Germa, Caroline; Hirawat, Samit; Lu, Yen-Shen The Lancet Oncology, Vol.19 No.7, pp.904-915	DOI
2018-07	Phase 1 studies of poziotinib, an irreversible pan-her tyrosine kinase inhibitor in patients with advanced solid tumors Kim, Tae Min; Lee, Keun-Wook; Oh, Do-Youn; Lee, Jong-Seok; Im, Seock-Ah; Kim, Dong-Wan; Han, Sae-Won; Kim, Yu Jung; Kim, Tae-You; Kim, Jee Hyun; Han, Hyesun; Kim, Woo Ho; Bang, Yung-Jue Cancer Research and Treatment, Vol.50 No.3, pp.835-842	DOI
2018-08	Phase III randomized study of ribociclib and fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: MONALEESA-3 Slamon, Dennis J.; Neven, Patrick; Chia, Stephen; Fasching, Peter A.; De Laurentiis, Michelino; Im, Seock-Ah; Petrakova, Katarina; Bianchi, Giulia Val; Esteva, Francisco J.; Martin, Miguel; Nusch, Arnd; Sonke, Gabe S.; De la Cruz-Merino, Luis; Beck, J. Thaddeus; Pivot, Xavier; Vidam, Gena; Wang, Yingbo; Lorenc, Karen Rodriguez; Miller, Michelle; Taran, Tetiana; Jerusalem, Guy Journal of Clinical Oncology, Vol.36 No.24, pp.2465-2472	DOI
2018-08	A first-in-human study of the new oral selective estrogen receptor degrader AZD9496 for ER+/HER2- advanced breast cancer Hamilton, Erika P.; Patel, Manish R.; Armstrong, Anne C.; Baird, Richard D.; Jhaveri, Komal; Hoch, Matthias; Klinowska, Teresa; Lindemann, Justin P. O.; Morgan, Shethah R.; Schiavon, Gaia; Weir, Hazel M.; Im, Seock-Ah Clinical Cancer Research, Vol.24 No.15, pp.3510-3518	DOI
2018-09	Palbociclib plus endocrine therapy in older women with HR+/HER2- advanced breast cancer: A pooled analysis of randomised PALOMA clinical studies Rugo, Hope S.; Turner, Nicholas C.; Finn, Richard S.; Joy, Anil A.; Verma, Sunil; Harbeck, Nadia; Masuda, Norikazu; Im, Seock-Ah; Huang, Xin; Kim, Sindy; Sun, Wan; Iyer, Shrividya; Schnell, Patrick; Bartlett, Cynthia Huang; Johnston, Stephen European Journal of Cancer, Vol.101, pp.123-133	DOI
2018-10	Oncologic safety of gonadotropin-releasing hormone agonist for ovarian function protection during breast cancer chemotherapy Kim, Hee Jeong; Lee, Moo Hyun; Lee, Jeong Eon; Park, Seho; Lee, Eun Sook; Kang, Yong Joon; Shin, Hae Na; Kim, Seung Il; Lee, Jun Ho; Im, Seock Ah; Ahn, Sei Hyun; Lee, Keun Seok; Sohn, Joohyuk; Kim, Seonok; Nam, Seok Jin; Han, Wonshik Clinical Breast Cancer, Vol.18 No.5, pp.e1165-e1172	DOI
2018-11	Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer Schmid, P.; Adams, S.; Rugo, H. S.; Schneeweiss, A.; Barrios, C. H.; Iwata, H.; Dieras, V.; Hegg, R.; Im, S. -A.; Wright, G. Shaw; Henschel, V.; Molinero, L.; Chui, S. Y.; Funke, R.; Husain, A.; Winer, E. P.; Loi, S.; Emens, L. A. New England Journal of Medicine, Vol.379 No.22, pp.2108-2121	DOI
2018-11	Overall survival with palbociclib and fulvestrant in advanced breast cancer Turner, Nicholas C.; Slamon, Dennis J.; Ro, Jungsil; Bondarenko, Igor; Im, Seock-Ah; Masuda, Norikazu; Colleoni, Marco; DeMichele, Angela; Loi, Sherene; Verma, Sunil; Iwata, Hiroji; Harbeck, Nadia; Loibl, Sibylle; Andre, Fabrice; Theall, K. Puyana; Huang, Xin; Giorgetti, Carla; Bartlett, C. Huang; Cristofanilli, Massimo New England Journal of Medicine, Vol.379 No.20, pp.1926-1936	DOI
2018-11	Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2 Campone, Mario; Im, Seock-Ah; Iwata, Hiroji; Clemons, Mark; Ito, Yoshinori; Awada, Ahmad; Chia, Stephen; Jagiello-Gruszfeld, Agnieszka; Pistilli, Barbara; Tseng, Ling-Ming; Hurvitz, Sara; Masuda, Norikazu; Cortes, Javier; De Laurentiis, Michele; Arteaga, Carlos L.; Jiang, Zefei; Jonat, Walter; Le Mouhaer, Sylvie; Sankaran, Banu; Bourdeau, Laurence; El-Hashimy, Mona; Sellami, Dalila; Baselga, Jose European Journal of Cancer, Vol.103, pp.147-154	DOI
2018-11	Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3 Cristofanilli, Massimo; DeMichele, Angela; Giorgetti, Carla; Turner, Nicholas C.; Slamon, Dennis J.; Im, Seock-Ah; Masuda, Norikazu; Verma, Shailendra; Loi, Sherene; Colleoni, Marco; Theall, Kathy Puyana; Huang, Xin; Liu, Yuan; Bartlett, Cynthia Huang European Journal of Cancer, Vol.104, pp.21-31	DOI
2018-11	Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre, open-label, three-arm, randomised phase II trial (FLAG study) Kim, Ji-Yeon; Im, Seock-Ah; Jung, Kyung Hae; Ro, Jungsil; Sohn, Joohyuk; Kim, Jee Hyun; Park, Yeon Hee; Kim, Tae-Yong; Kim, Sung-Bae; Lee, Keun Seok; Kim, Gun Min; Kim, Se Hyun; Kim, Seonwoo; Ahn, Jin Seok; Lee, Kyung-Hun; Ahn, Jin-Hee; Park, In Hae; Im, Young-Hyuck European Journal of Cancer, Vol.103, pp.127-136	DOI
2018-12	nCirculating biomarkers and resistance to endocrine therapy in metastatic breast cancers: Correlative results from AZD9496 oral SERD phase I trial Paoletti, Costanza; Schiavon, Gaia; Dolce, Emily M.; Darga, Elizabeth P.; Carr, T. Hedley; Geradts, Joseph; Hoch, Matthias; Klinowska, Teresa; Lindemann, Justin; Marshall, Gayle; Morgan, Shethah; Patel, Parul; Rowlands, Vicky; Sathiyayogan, Nitharsan; Aung, Kimberly; Hamilton, Erika; Patel, Manish; Armstrong, Anne; Jhaveri, Komal; Im, Seock-Ah; Iqbal, Nadia; Butt, Fouziah; Dive, Caroline; Harrington, Elizabeth A.; Barrett, J. Carl; Baird, Richard; Hayes, Daniel F. Clinical Cancer Research, Vol.24 No.23, pp.5860-5872	DOI
2018-12	A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial Park, Yeon Hee; Lee, Kyung-Hun; Sohn, Joo Hyuk; Lee, Keun Seok; Jung, Kyung Hae; Kim, Jee-Hyun; Lee, Ki Hyeong; Ahn, Jin Seok; Kim, Tae-Yong; Kim, Gun Min; Park, In Hae; Kim, Sung-Bae; Kim, Se Hyun; Han, Hye Sook; Im, Young-Hyuck; Ahn, Jin-Hee; Kim, Jung-Yong; Kang, Jahoon; Im, Seock-Ah International Journal of Cancer, Vol.143 No.12, pp.3240-3247	DOI
2018-12	Effects of trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-overexpressing breast cancer patients treated with chemotherapy and radiotherapy Jeon, Seung Hyuck; Shin, Kyung Hwan; Kim, Jin Ho; Kim, Kyubo; Kim, In Ah; Lee, Kyung-Hun; Kim, Tae-Yong; Im, Seock-Ah Breast Cancer Research and Treatment, Vol.172 No.3, pp.619-626	DOI
2018-12	Androgen receptor inhibitor enhances the antitumor effect of PARP inhibitor in breast cancer cells by modulating DNA damage response Min, Ahrum; Jang, Hyemin; Kim, Seongyeong; Lee, Kyung-Hun; Kim, Debora Keunyoung; Suh, Koung Jin; Yang, Yaewon; Elvin, Paul; O'Connor, Mark J.; Im, Seock-Ah Molecular Cancer Therapeutics, Vol.17 No.12, pp.2507-2518	DOI
2019-01	Landscape of actionable genetic alterations profiled from 1,071 tumor samples in Korean cancer patients Lee, Se-Hoon; Lee, Boram; Shim, Joon Ho; Lee, Kwang Woo; Yun, Jae Won; Kim, Sook-Young; Kim, Tae-You; Kim, Yeul Hong; Ko, Young Hyeh; Chung, Hyun Cheol; Yu, Chang Sik; Lee, Jeeyun; Rha, Sun Young; Kim, Tae Won; Jung, Kyung Hae; Im, Seock-Ah; Moon, Hyeong-Gon; Cho, Sukki; Kang, Jin Hyoung; Kim, Jihun; Kim, Sang Kyum; Ryu, Han Suk; Ha, Sang Yun; Kim, Jong Il; Chung, Yeun-Jun; Kim, Cheolmin; Kim, Hyung-Lae; Park, Woong-Yang; Noh, Dong-Young; Park, Keunchil Cancer Research and Treatment, Vol.51 No.1, pp.211-222	DOI
2019-01	Randomized Open Labe Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01) Park, In Hae; Im, Seock-Ah; Jung, Kyung Hae; Sohn, Joo Hyuk; Park, Yeon Hee; Lee, Keun Seok; Sim, Sung Hoon; Park, Kyong-Hwa; Kim, Jee Hyun; Nam, Byung Ho; Kim, Hee-Jun; Kim, Tae-Yong; Lee, Kyung-Hun; Kim, Sung-Bae; Ahn, Jin-Hee; Lee, Suee; Ro, Jungsil Cancer Research and Treatment, Vol.51 No.1, pp.43-52	DOI
2019-01	MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer Johnston, Stephen; Martin, Miguel; Di Leo, Angelo; Im, Seock-Ah; Awada, Ahmad; Forrester, Tammy; Frenzel, Martin; Hardebeck, Molly C.; Cox, Joanne; Barriga, Susana; Toi, Masakazu; Iwata, Hiroji; Goetz, Matthew P. npj Breast Cancer, Vol.5 No.1, p. 5	DOI
2019-04	Pan-PIM kinase inhibitor AZD1208 suppresses tumor growth and synergistically interacts with AKT inhibition in gastric cancer cells Lee, Miso; Lee, Kyung-Hun; Min, Ahrum; Kim, Jeongeun; Kim, Seongyeong; Jang, Hyemin; Lim, Jee Min; Kim, So Hyeon; Ha, Dong-Hyeon; Jeong, Won Jae; Suh, Koung Jin; Yang, Yae-Won; Kim, Tae Yong; Oh, Do-Youn; Bang, Yung-Jue; Im, Seock-Ah Cancer Research and Treatment, Vol.51 No.2, pp.451-463	DOI
2019-04	OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer Robson, M. E.; Tung, N.; Conte, P.; Im, S. -A.; Senkus, E.; Xu, B.; Masuda, N.; Delaloge, S.; Li, W.; Armstrong, A.; Wu, W.; Goessl, C.; Runswick, S.; Domchek, S. M. Annals of Oncology, Vol.30 No.4, pp.558-566	DOI
2019-05	Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11) Kim, Ji-Yeon; Park, Seri; Im, Seock-Ah; Kim, Sung-Bae; Sohn, Joohyuk; Lee, Keun Seok; Chae, Yee Soo; Lee, Ki Hyeong; Kim, Jee Hyun; Im, Young-Hyuck; Kim, Tae-Yong; Lee, Kyung-Hun; Ahn, Jin-Hee; Kim, Gun Min; Park, In Hae; Lee, Soo Jung; Han, Hye Sook; Kim, Se Hyun; Jung, Kyung Hae; Park, Yeon Hee Cancer Communications, Vol.39 No.1, pp.1-8	view file DOI
2019-05	Palbociclib plus letrozole as first-line therapy in postmenopausal Asian women with metastatic breast cancer: Results from the phase III, randomized PALOMA-2 study Im, Seock-Ah; Mukai, Hirofumi; Park, In Hae; Masuda, Norikazu; Shimizu, Chikako; Kim, Sung-Bae; Im, Young-Hyuck; Ohtani, Shoichiro; Bartlett, Cynthia Huang; Lu, Dongrui R.; Iyer, Shrividya; Mori, Yuko; Mori, Ave; Gauthier, Eric; Finn, Richard S.; Toi, Masakazu Journal of Global Oncology, Vol.2019 No.5, pp.1-19	DOI
2019-05	Prognostic effects of abnormal DNA damage response protein expression in breast cancer Suh, Koung Jin; Ryu, Han Suk; Lee, Kyung-Hun; Kim, Hyojin; Min, Ahrum; Kim, Tae-Yong; Yang, Yaewon; Lee, Han-Byoel; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Im, Seock-Ah Breast Cancer Research and Treatment, Vol.175 No.1, pp.117-127	DOI
2019-06	Challenges and insights of early oncology drug development in the Asia-Pacific region: introduction of phase I oncology clinical trial center and experience sharing for early clinical trials in Seoul National University Hospital, Korea Im, Seock-Ah; Lee, Dae-Won; Kang, Ryungwoo; Kim, Jee Hyun; Kim, Dong-Wan; Jang, In-Jin; Lee, Jong-Seok; Bang, Yung-Jue Chinese Clinical Oncology, Vol.8 No.3, p. 27	view file DOI
2019-07	Overall survival with ribociclib plus endocrine therapy in breast cancer Im, Seock-Ah; Lu, Yen-Shen; Bardia, Aditya; Harbeck, Nadia; Colleoni, Marco; Franke, Fabio; Chow, Louis; Sohn, Joohyuk; Lee, Keun-Seok; Campos-Gomez, Saul; Villanueva-Vazquez, Rafael; Jung, Kyung-Hae; Chakravartty, Arunava; Hughes, Gareth; Gounaris, Ioannis; Rodriguez-Lorenc, Karen; Taran, Tetiana; Hurvitz, Sara; Tripathy, Debu New England Journal of Medicine, Vol.381 No.4, pp.307-316	DOI
2019-07	Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients Kim, Jung Youn; Lee, Dae-Won; Lee, Kyung-Hun; Min, Ahrum; Ryu, Han Suk; Lee, Han-Byoel; Moon, Hyeong-Gon; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Im, Seock-Ah; Kim, Sukil Breast Cancer Research and Treatment, Vol.176 No.2, pp.453-460	DOI
2019-07	Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I–III breast cancer patients Lee, Dae-Won; Ryu, Han Suk; Jin, Min-Sun; Lee, Kyung-Hun; Suh, Koung Jin; Youk, Jeonghwan; Kim, Jung Youn; Min, Ahrum; Lee, Han-Byoel; Moon, Hyeong-Gon; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Im, Seock-Ah British Journal of Cancer, Vol.121 No.3, pp.230-236	DOI
2019-09	Molecular alterations and poziotinib efficacy, a pan-HER inhibitor, in human epidermal growth factor receptor 2 (HER2)-positive breast cancers: Combined exploratory biomarker analysis from a phase II clinical trial of poziotinib for refractory HER2-positive breast cancer patients Kim, Ji-Yeon; Lee, Eunjin; Park, Kyunghee; Jung, Hae Hyun; Park, Woong-Yang; Lee, Kyung-Hun; Sohn, Joohyuk; Lee, Keun Seok; Jung, Kyung Hae; Kim, Jee Hyun; Lee, Ki Hyeong; Im, Seock-Ah; Park, Yeon Hee International Journal of Cancer, Vol.145 No.6, pp.1669-1678	DOI
2019-09	성인 고형암 환자의 고칼슘혈증 치료현황과 치료효과 분석 신다은; 박설희; 김성환; 서성연; 조윤희; 조윤숙; 임석아; 이주연 한국임상약학회지, Vol.29 No.3, pp.166-172	DOI
2019-09	Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer Luo, Yang; Li, Wei; Jiang, Zefei; Zhang, Qingyuan; Wang, Liwei; Mao, Yixiang; Tjan-Heijnen, Vivianne C. G.; Im, Seock-Ah; McConnell, Robin; Bejarano, Sara; Fumagalli, Debora; Bines, Jose; Wang, Bei; Garg, Amit; Kirschbrown, Whitney P.; Xu, Binghe Anti-Cancer Drugs, Vol.30 No.8, pp.866-872	DOI
2019-10	The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab Shin, Jung Won; Kim, Soohyun; Ha, Suji; Choi, Byungsan; Kim, Seongyeong; Im, Seock-Ah; Yoon, Tae-Young; Chung, Junho Biomolecules, Vol.9 No.10, p. 629	DOI
2019-10	Ribociclib and Endocrine Therapy in Breast Cancer REPLY Im, Seock-Ah; Lu, Yen-Shen; Tripathy, Debu New England Journal of Medicine, Vol.381 No.16, pp.1592-1593	DOI
2019-10	Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial Robson, Mark; Ruddy, Kathryn J.; Im, Seock-Ah; Senkus, Elzbieta; Xu, Binghe; Domchek, Susan M.; Masuda, Norikazu; Li, Wei; Tung, Nadine; Armstrong, Anne; Delaloge, Suzette; Bannister, Wendy; Goessl, Carsten; Degboe, Arnold; Hettle, Robert; Conte, Pierfranco European Journal of Cancer, Vol.120, pp.20-30	DOI
2019-10	Treating HR+/HER2-breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression Yeo, Winnie; Ueno, Takayuki; Lin, Ching-Hung; Liu, Qiang; Lee, Kyung-Hun; Leung, Roland; Naito, Yoichi; Park, Yeon Hee; Im, Seock-Ah; Li, Huiping; Yap, Yoon Sim; Lu, Yen-Shen Breast Cancer Research and Treatment, Vol.177 No.3, pp.549-559	DOI
2019-11	Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11) Kim, Ji-Yeon; Lee, Eunjin; Park, Kyunghee; Im, Seock-Ah; Sohn, Joohyuk; Lee, Keun Seok; Chae, Yee Soo; Kim, Jee Hyun; Kim, Tae-Yong; Jung, Kyung Hae; Park, Yeon Hee Breast Cancer Research and Treatment, Vol.178 No.2, pp.367-377	DOI
2019-12	Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2+metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16) Sim, Sung Hoon; Park, In Hae; Jung, Kyung Hae; Kim, Sung-Bae; Ahn, Jin-Hee; Lee, Kyung-Hun; Im, Seock-Ah; Im, Young-Hyuck; Park, Yeon Hee; Sohn, Joohyuk; Kim, Yu Jung; Lee, Suee; Kim, Hee-Jun; Chae, Yee Soo; Park, Kyong Hwa; Nam, Byung-Ho; Lee, Keun Seok; Ro, Jungsil British Journal of Cancer, Vol.121 No.12, pp.985-990	DOI
2019-12	Amenorrhea and menopause in patients with breast cancer after chemotherapy Shin, Jae Jun; Choi, Young Min; Jun, Jong Kwan; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Wonshik; Im, Seock-Ah Journal of Breast Cancer, Vol.22 No.4, pp.624-634	DOI

1 5 6 7 8 9 10